Introduction {#s1}
============

The molecular mechanisms underlying animal multicellularity evolved, in part, through the modification of ancient adhesion and signaling pathways found in the unicellular and colonial progenitors of animals. The evolution of the animal molecular toolkit may be reconstructed through the study of the choanoflagellates, the closest living relatives of animals ([@bib29]; [@bib11]; [@bib50]; [@bib47]; [@bib46]). For example, despite the fact that choanoflagellates are not animals, they express diverse genes required for animal multicellularity, including C-type lectins, cadherins, and tyrosine kinases ([@bib1]; [@bib26]; [@bib37]; [@bib42]; [@bib56]; [@bib19]), demonstrating that these genes predate the origin of animals. In addition, the architecture of choanoflagellate cells is conserved with animals and helps to illuminate the ancestry of animal cell biology ([@bib43]; [@bib49]; [@bib3]).

The colony-forming species *Salpingoeca rosetta* promises to be particularly informative about the origins of cell differentiation, intercellular interactions, and multicellular development in animals. Through a process that resembles the earliest stages of embryogenesis in marine invertebrates, single cells of *S. rosetta* undergo serial rounds of cell division to develop into spherical rosette colonies (hereafter, 'rosettes'; [Figure 1](#fig1){ref-type="fig"}) ([@bib18]; [@bib14]). Rosette development in choanoflagellates mirrors the transition to multicellularity that is hypothesized to have preceded the origin of animals ([@bib21]; [@bib43]; [@bib40]), although its relationship to animal development is unknown. Recent improvements to the phylogeny of choanoflagellates reveal that colony development may have an ancient origin that extends to the first choanoflagellates and possibly to the last common ancestor of choanoflagellates and animals ([@bib44]). The possibility that choanoflagellate colony development and animal embryogenesis have a common evolutionary history is brought into greater relief when compared with the quite different process of development observed in outgroups of the animal + choanoflagellate clade (e.g., *Capsaspora owczarzaki;* [@bib55]), in which isolated cells with different genotypes gather into aggregates.10.7554/eLife.04070.003Figure 1.*S. rosetta*: an emerging model for studying animal origins and multicellularity.*S. rosetta* cells are polarized, each having a single apical flagellum encircled by a collar of microvilli (bracket), shown in cross-sectional diagram (**A**) and through DIC imaging of a live cell (**B**). In rosette colonies (**C**), each cell is oriented around a central point, with the flagella facing outward. Bacterial prey (∼1 µm rods) attach transiently to the collars of some cells prior to ingestion by phagocytosis. Scale bar = 10 µm. (**D**) *S. rosetta* transitions between several morphologically differentiated cell types during its life history: rosette colonies (RC), chain colonies (CC), slow swimmers (SS), fast swimmers (FS), and thecate cells (TC). The transition from slow swimmers to rosette colonies (star) is induced by lipids from the bacterium *Algoriphagus machipongonensis* and can be regulated in the laboratory. (**E**) *S. rosetta* undergoes a sexual cycle in the laboratory. When starved, haploid cultures produce anisogamous gametes that are capable of mating to produce diploids. Diploids undergo meiosis and thereby produce haploids when grown in nutrient-rich media. Haploids and diploids can also reproduce asexually through mitosis.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.003](10.7554/eLife.04070.003)

*S. rosetta* is also notable for its experimental tractability relative to other choanoflagellate species. Importantly, the switch between the *S. rosetta* solitary life style and rosette development is regulated by specific lipids produced by the prey bacterium *Algoriphagus machipongonensis* ([@bib4]). Thus, rosette development can be induced in the laboratory. Moreover, the genome and transcriptome of *S. rosetta* have been sequenced and analyzed, revealing numerous homologs of diverse animal genes, many of which are up-regulated in colonies ([@bib19]). However, the roles of animal gene homologs in choanoflagellates have not been determined, and there have not been any published reports of successful disruptions to choanoflagellate gene function (including gene deletions, RNA interference, or transgene expression). Indeed, no direct functional links have yet been drawn between genotype and phenotype for any choanoflagellate gene or trait. We recently found that *S. rosetta* can be induced to undergo sex and meiosis, suggesting that it may be amenable to mapping crosses ([@bib32]). Therefore, to determine the genetic basis of rosette development and investigate its relationship to animal development, we set out to establish forward genetics in *S. rosetta*.

Results {#s2}
=======

Isolation of mutants with diverse rosette defects {#s2-1}
-------------------------------------------------

To induce mutations in *S. rosetta*, cultures of haploid cells were exposed either to 0.3% EMS or 6300 rems X-rays, which resulted in a 10% or 40% reduction in cell number, respectively, when averaged across multiple trials ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). We elected to use these relatively light mutagen doses to minimize the number of background mutations in any mutant of interest. After exposing cells to either EMS or X-rays, clonal lines of potential mutants were established by isolating individual cells through limiting dilution (i.e., on average, plating less than one cell/well) into 96-well plates containing rosette-inducing *A. machipongonensis* conditioned media (ACM; [Figure 2](#fig2){ref-type="fig"}). After 5 to 7 days, each well seeded with a wild-type cell was filled with rosettes, while wells seeded with mutant cells defective in rosette development were expected to produce cultures of solitary cells and/or chain colonies, but few to no rosettes, even in the presence of ACM.10.7554/eLife.04070.004Figure 2.A screen for rosette defect mutants in *S. rosetta*.Rosette defect mutants were isolated by exposing *S. rosetta* haploid cells to either EMS or X-rays and then isolating clones in rosette-inducing *Algoriphagus* conditioned media (ACM) prior to visual screening. The use of limiting dilution to isolate clones resulted in many wells with no cells (indicated as white circles). Wells seeded with a wild-type cell (gray circles) produced a culture with abundant rosette colonies, while wells seeded with a rosette defect mutant (black circle) produced a culture with chains or single cells, but few to no chain colonies. Candidate rosette defect mutants were validated through repeated rounds of limiting dilution prior to re-screening in ACM.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.004](10.7554/eLife.04070.004)

We screened 15,344 clonal cultures for the presence or absence of rosettes ([Figure 2](#fig2){ref-type="fig"}). Nine mutants with validated rosette defects were isolated ('Materials and methods'), each of which showed a significant reduction in rosette development relative to wild type ([Figure 3A](#fig3){ref-type="fig"}). The nine rosette defect mutants fell into seven phenotypic classes (classes A--G, [Table 1](#tbl1){ref-type="table"}; [Figure 3](#fig3){ref-type="fig"}) based upon their ability to form rosette colonies in the presence of ACM or live *A. machipongonensis*, their swimming behavior as solitary cells, and the morphology of chain colonies produced when grown in the absence of ACM.10.7554/eLife.04070.005Table 1.Classification of mutant phenotypes**DOI:** [http://dx.doi.org/10.7554/eLife.04070.005](10.7554/eLife.04070.005)Mutagen usedObserved rosette induction[\*](#tblfn1){ref-type="table-fn"}Other phenotypesACMLive bacteriaSwimming[†](#tblfn2){ref-type="table-fn"}Chain morphologyWild typeN/A86%88%Wild typePrimarily linearMutant class A RosettelessEMS00Wild typePrimarily linearMutant class B InsensateX-rays05Wild typePrimarily linearMutant class C SlackerX-rays2042Wild typePrimarily linearMutant class D UptightX-rays3356Wild typeBranchedMutant class E JumbleEMS00Wild typeBranched BranchedX-rays00Wild typeBranchedMutant class F SeafoamX-rays00Wild typeLarge clusters SoapsudsX-rays00Wild typeLarge clustersMutant class G SoloX-rays00Slow, shakingPrimarily solitary[^1][^2]10.7554/eLife.04070.006Figure 3.Phenotypes of diverse rosette defect mutants.(**A**) Cultures of all nine mutants isolated in this study showed a significantly reduced number of cells in rosettes relative to wild type (one-tailed Mann--Whitney test, p \< 0.01). Rosette development was measured as the % of cells in rosettes after 48 hr in 20% ACM, shown as mean ± SEM. Ø indicates mutants in which no rosettes were observed (limit of detection = 0.03%). (**B**) Wild-type *S. rosetta* grown without ACM formed flexible, linear chains or single cells ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). When exposed to ACM, wild-type *S. rosetta* cultures produced spherical rosettes (arrowheads). Rosetteless cultures did not form rosettes in ACM, but otherwise appeared in wild type, forming normal chain colonies and proliferating at rates indistinguishable from wild-type *S. rosetta* ([Figures 3---figure supplement 1B,E and 2](#fig3s1 fig3s2){ref-type="fig"}). (**C**) Unlike Rosetteless, the remaining eight rosette defect mutants showed additional phenotypic aberrations. Although a small percentage of Slacker and Uptight cells were found in bona fide rosettes (arrowheads), most remained as single cells or chain colonies that were easily disrupted when exposed to shear ([Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}). Seafoam and Soapsuds formed large, disorganized clusters of cells that were easily disrupted when exposed to shear ([Figure 3---figure supplement 1E and 2](#fig3s1 fig3s2){ref-type="fig"}) and were thus not rosettes. Scale bars = 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.006](10.7554/eLife.04070.006)10.7554/eLife.04070.007Figure 3---figure supplement 1.Mutagenesis and mutant phenotypes.(**A**) Vertical scatter plot showing the effect of mutagenesis on cell number, shown as the number of mutagenized cells divided by the number of cells in a paired, unmutagenized culture at 24 hr post-mutagenesis. Each dot represents one mutagenesis experiment and the mutagenesis from which the Rosetteless mutant was isolated is highlighted (red). The dotted line at 1.0 represents no effect. The mutagen doses used in the screen were 0.3% EMS (vol/vol) and 6300 rem X-rays, which each resulted, on an average, in a decrease in cell number (p \< 0.05, Wilcoxon signed rank test). (**B**) Growth curve of wild-type (open circles, dotted line) and Rosetteless mutant (filled circles, solid line) cells shows that the Rosetteless phenotype is not due to a growth defect. Error bars show standard deviation. (**C**) Quantification of rosette induction in the presence of live *A. machipongonensis*, shown as mean ± SEM. Ø represents cultures in which no rosettes were observed (limit of detection = 0.03%). Compare to [Figure 3B](#fig3){ref-type="fig"} to see rosette induction from *A. machipongonensis* conditioned media (ACM) rather than live bacteria. Notably, the insensate mutant shows a low level of rosette induction when exposed to live bacteria but not when exposed to ACM. (**D**) Single confocal slices through rosettes stained with FM 1--43X dye showed differences in cell packing within wild-type and uptight mutant rosettes. Bottom: inverted images were false colored to mark the space between cells in the center of the rosette. Scale bar = 5 µm. (**E**) Phenotypes of rosette defect mutants after vigorous pipetting. Rosettes (red arrowheads) form in the presence of ACM and are robust to pipetting, whereas chain colonies break up into single cells. The uptight mutant occasionally formed rosettes, but none were visible in this field of view. Scale bar = 20 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.007](10.7554/eLife.04070.007)10.7554/eLife.04070.008Figure 3---figure supplement 2.Chain colony morphologies of diverse mutants.*S. rosetta* chain colonies from wild-type and mutant cultures grown without exposure to *A. machipongonensis* signals are shown at low magnification to document the morphologies of numerous chain colonies. Each phase-bright circle is a choanoflagellate cell, while the dark specks are bacteria. To the right of each image, the cells of each in focus chain colony have been false colored blue to identify chains and emphasize chain morphology. Three mutants (Rosetteless, Insensate, and Slacker) exhibit essentially wild-type chains. Solo is largely single-celled and rarely forms chains. The five remaining mutants all form chains that are more branched or highly clustered than wild-type chains. Scale bar = 50 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.008](10.7554/eLife.04070.008)

Class A consisted of a single mutant, named Rosetteless, that was isolated after EMS treatment. In the presence of either ACM or live *A. machipongonensis,* Rosetteless cells failed entirely to develop into rosettes, but their cell morphology and proliferation were otherwise indistinguishable from wild type ([Figure 3B](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). Mutants from classes B--D formed some rosettes, but significantly fewer than wild-type strains, and class D exhibited altered spacing and orientation of cells within the rare rosettes that formed ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1C and D](#fig3s1){ref-type="fig"}). Rosette development was never observed in mutants from classes E--G ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1C,E](#fig3s1){ref-type="fig"}, [Table 1](#tbl1){ref-type="table"}).

Although *S.rosetta* was originally isolated as a rosette, wild-type cells can produce linear, 'chain' colonies when grown without *A. machipongonensis* ([Figure 1](#fig1){ref-type="fig"}). Rosettes and chain colonies can be easily distinguished from each other. In addition to the differences in their morphology, the connections among cells in rosettes are robust and resistant to mechanical shear, whereas chain colonies are fragile and readily fall apart into individual cells when exposed to shear forces. Nonetheless, chain colonies and rosettes have some similarities, including the presence of fine intercellular bridges connecting neighboring cells and similar transcriptional profiles ([@bib14]; [@bib19]). We therefore investigated whether the rosette defect mutants had co-occurring defects in their ability to form normal chain colonies with linear morphology. Mutant classes A--C formed apparently wild-type chain colonies. In contrast, classes D--F developed into highly branched chain colonies while cultures of the class G mutant, which rarely formed chains, were instead observed to be predominantly single celled ([Table 1](#tbl1){ref-type="table"}, [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}).

The ability to isolate mutants with a range of rosette and chain phenotypes demonstrates the potential of forward genetics to illuminate diverse aspects of multicellular development in *S. rosetta*.

Rosetteless phenotype maps to the gene *EGD82922* {#s2-2}
-------------------------------------------------

The Rosetteless mutant phenotype was highly penetrant and yet the mutant lacked any other obvious defects ([Figure 3](#fig3){ref-type="fig"}, [Figures 3---figure supplement 1B and 2](#fig3s1 fig3s2){ref-type="fig"}). We thus inferred that the gene(s) disrupted in the Rosetteless mutant might have roles specific to rosette development. Therefore, as we set out to establish methods for mapping mutations in *S. rosetta*, we focused on the Rosetteless mutant. We started by sequencing Rosetteless and two closely related wild-type strains (the parental strain from which Rosetteless was isolated and C2E5, a co-isolated wild-type strain) to identify sequence variants that could serve as genetic markers ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}, 'Materials and methods'), with the understanding that one or more of the detected sequence variants might ultimately prove to be the causative mutation(s). After filtering the sequence variants by quality, we identified 25,160 potential genetic markers that differed between Rosetteless and the reference genome sequence, only four of which were unique to the Rosetteless genome ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

Our recent discovery of the sexual cycle of *S. rosetta* ([@bib32]) suggested that it might be possible to perform a choanoflagellate mapping cross to identify the mutation(s) responsible for the Rosetteless phenotype. To this end, Rosetteless was mated with another, previously sequenced *S. rosetta* strain, Isolate B ([@bib32]), that carried 39,451 putative sequence polymorphisms relative to Rosetteless ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Using a combination of serial dilutions and genotyping, we isolated seven outcrossed diploids and established clonal cultures ([Figure 4](#fig4){ref-type="fig"}, 'Materials and methods'). In the second phase of the mapping cross, the heterozygous diploid cultures were expanded and divided into multiple flasks, rapidly passaged in rich media to induce meiosis, and subjected to another round of serial dilution to generate clonal cultures. Of 442 clonal cultures genotyped, 182 were haploid progeny of the cross, as evidenced by their homozygosity at three microsatellite markers ('Materials and methods').10.7554/eLife.04070.009Figure 4.Rosetteless maps to *EGD82922*.(**A**) Design of the mapping cross. Rosetteless cells were mixed with Isolate B, an *S. rosetta* culture capable of forming rosettes. Mating was induced by starvation. To isolate the products of outcrossed mating, cells then underwent clonal isolation, and clonal populations were genotyped to identify outcrossed, diploid heterozygotes. These heterozygotes were expanded and induced to undergo meiosis, after which clonal isolation and genotyping were repeated. Haploid progeny of the cross were homozygous at all three markers. (**B**) 2 × 2 contingency table shows that the Rosetteless phenotype was tightly linked to the genotype of the supercontig 8: 427,804 candidate splice donor mutation. (**C**) Map of the supercontig 8 markers. Top numbers show the genetic distance between the markers and the Rosetteless phenotype in centimorgans (cM). Bottom numbers show marker genomic positions on supercontig 8. Black lines within the central bar show all sites of predicted polymorphism (i.e., possible marker positions) between Rosetteless and Isolate B. The blue marker is the *EGD82922* splice donor mutation.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.009](10.7554/eLife.04070.009)10.7554/eLife.04070.010Figure 4---source data 1.Full genotyping data for all progeny of the Rosetteless x Isolate B cross.For each isolated progeny of the cross, we provide the phenotype when grown in HN media (chains or rosettes), the identity of the heterozygous flask from which the haploid isolate was derived ('Flask isolated from'), and the genotypes at 60 SNV and microsatellite loci. For the microsatellite loci, numbers indicate the approximate size of the amplicon. Missing genotype data is indicated by 'NA'. Color-coding shows genotypes and phenotypes that match Isolate B (white) or Rosetteless (yellow). Genotyping data was used to construct a linkage map for *S. rosetta* ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). For each marker, we list its linkage group and its inferred position within the linkage group. Four of the cross isolates were excluded from further analyses because their genotypes were identical to other cross isolates.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.010](10.7554/eLife.04070.010)10.7554/eLife.04070.011Figure 4---figure supplement 1.Identification of Rosetteless-specific mutations.(**A**) Venn diagram of the high-quality single nucleotide variants (SNVs) detected in the genome sequences of Rosetteless, the parental strain, and a co-isolated wild-type strain as compared to the *S. rosetta* reference genome. The vast majority of detected SNVs (25,055) were shared among all three isolates. Only 17 unique, high-quality SNVs were predicted in Rosetteless. (**B**) The seventeen predicted, Rosetteless-specific SNV calls. Genotyping of Rosetteless and wild-type *S. rosetta* was used to determine whether the putative unique SNV was verified (V, present in Rosetteless but absent in wild type), a false positive (FP, absent from both Rosetteless and wild type), a false negative (FN, present in both Rosetteless and wild type), or a mistakenly called SNV in a region where the *S. rosetta* reference genome was misassembled (GM). The SNV on supercontig 8 (bold) was the only one predicted to alter a coding region. (**C**) Cloning and Sanger sequencing confirmed that the supercontig 8: 427,804 SNV was polymorphic between Rosetteless and the parental strain. Note that the Sanger sequencing shown here was from the + strand, while the gene is encoded on the---strand.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.011](10.7554/eLife.04070.011)10.7554/eLife.04070.012Figure 4---figure supplement 2.Map of polymorphisms and markers used in the cross.Horizontal bars represent the 25 largest supercontigs in the *S. rosetta* genome. The positions of each predicted polymorphism, based on comparisons of the genome sequences of Rosetteless and Isolate B, are vertical lines mapped semi-transparently in black, such that regions with high variant density are darker than those with lower variant density. Red arrows show positions genotyped in all cross isolates, including the perfectly linked supercontig 8: 427,804 mutation (\*, [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}). Note that the supercontig 8: 427,804 mutation lies within a haplotype block with little to no polymorphism between Rosetteless and Isolate B.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.012](10.7554/eLife.04070.012)10.7554/eLife.04070.013Figure 4---figure supplement 3.A linkage map for *S. rosetta*.Linkage map of *S. rosetta*, based on the genotypes of the 178 independent Rosetteless--Isolate B cross progeny (LOD cutoff = 5). The color of each box represents the genetic distance between two markers (shades of gray; see key) or the genetic distance between a marker and the Rosetteless phenotype (shades of blue; see key), thresholded such that non-significant distances are white (one-tailed Fisher\'s exact test, p \> 0.05). The boxes representing the four SNVs that were unique to Rosetteless are outlined in red. Gray lines show the boundaries between assembled linkage groups, labeled at the top of the figure. The supercontig locations of each marker are listed, in order, on the left and bottom sides of the figure. Note that the Rosetteless phenotype (blue) is tightly linked only to the splice donor mutation and not to any of the other genomic positions or Rosetteless-specific SNVs. Although there was some observed linkage between linkage groups 2 and 3, this may be an artifact of the segregation distortion and so we conservatively assigned these to separate linkage groups. [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"} lists the exact genomic and linkage group positions for each marker.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.013](10.7554/eLife.04070.013)

Genotyping of each haploid isolate at 60 polymorphic sites across the genome revealed that most markers followed Mendel\'s law of Segregation and Independent Assortment ('Materials and methods', [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}) ([@bib39]); thus *S. rosetta* inheritance appears to follow the rules of classical genetics. Analysis of the genotyping data in haploids also revealed genetic linkage among some of the markers, allowing us to generate a linkage map containing 27 preliminary linkage groups that represent approximately 70% of the *S. rosetta* genome ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}, [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}).

Most importantly, the genotype data revealed only one mutation (supercontig 8, position 427,804) that was tightly linked (\<0.56 cM) to the rosette defect phenotype. The presence of the mutation was linked to the presence of the Rosetteless phenotype in all examined haploid progeny from the Rosetteless × Isolate B cross (177/177, [Figure 4](#fig4){ref-type="fig"}). Moreover, the mutation was one of the four validated Rosetteless-specific SNVs and, by disrupting a splice donor in the gene *EGD82922*, was the only one predicted to cause a coding change ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). To investigate whether our variant calling method was too restrictive, we also genotyped the heterozygous diploids for 20 additional putative polymorphisms near the *EGD82922* marker, which were called below our quality threshold, and none proved to be polymorphic in this cross. Therefore, based on the tight linkage between the *EDG82922* mutation and the phenotype, as well as the absence of any other detected polymorphisms in the 5′ end of supercontig 8, we infer that the candidate splice donor mutation in the gene *EGD82922* is responsible for the rosette defect phenotype. We hereafter refer to *EGD82922* (Genbank accession XP_004995286) as *rosetteless* (*rtls*) and the relevant mutation as *rtls*^*l1*^.

A predicted C-type lectin required for rosette development {#s2-3}
----------------------------------------------------------

The *rtls* gene encodes a 119 kDa protein with an N-terminal signal peptide and two C-type lectin-like domains (CTLDs; [Figure 5A](#fig5){ref-type="fig"}). CTLD-containing proteins, including the C-type lectins, are found in all animal lineages and play diverse roles, including cell--cell adhesion, cell--extracellular matrix adhesion, cell signaling, and innate immune recognition of pathogens through their binding to carbohydrates, proteoglycans, lipids, and other ligands ([@bib51]; [@bib10]; [@bib61]; [@bib20]; [@bib57]). Similar to CTLDs from animals, the Rtls CTLDs contain four conserved cysteines required for two disulfide bonds, as well as the Glu-Pro-Asn motif ([Figure 5B](#fig5){ref-type="fig"}) that is required for mannose binding in some C-type lectins ([@bib17]). Nonetheless, because the CTLDs of Rtls have not yet been shown to bind sugar moieties, we follow the convention of the field and provisionally refer to Rtls as a C-type lectin-like protein. Rtls also contains several low-complexity regions that each consists of as many as 50--60 consecutive threonines and serines and two high-complexity internal repeat regions (RP1 and RP2) of unknown function near the C-terminus of the protein ([Figure 5A,C](#fig5){ref-type="fig"}). The serine-threonine-rich regions resemble mucin-like domains found in some animal C-type lectins and are likely sites of O-linked glycosylation ([@bib12]; [@bib16]). The *rtls*^*l1*^ mutation, a T-to-C mutation in the predicted splice donor of intron 7, falls 3′ of the sequences encoding the two CTLDs and 5′ of the RP1 and RP2 sequences ([Figure 5A](#fig5){ref-type="fig"}).10.7554/eLife.04070.014Figure 5.Gene structure, domain organization, and expression of *rtls*.(**A**) The *rtls* gene (top) contains 12 exons (numbered) and encodes a protein (bottom) with an amino-terminal signal peptide (green), two C-type lectin-like domains (CTLDs), extended stretches of serines and threonines (wavy lines), and two internal repeats of unknown function (RP1 and RP2). The *rtls*^*l1*^ SNV interrupts a splice donor in intron 7 (GT → GC). The epitope used to generate the anti-Rtls antibody is shown (orange bracket). (**B**) An alignment of Rtls CTLDs with CTLDs from rat surfactant protein A (rat SP-A, 1R13_A) and rat mannose-binding protein (rat MBP, 2MSB_A) revealed that residues used in disulfide bonds (blue), mannose-type sugar binding (red), and calcium ion binding (\*) are conserved. Other conserved or similar residues are highlighted in gray. (**C**) Alignment of the RP1 and RP2 regions. (**D**) RT-PCR of *rtls* with primers to the exon 5/6 junction and exon 12 showed that wild-type cells produce a single isoform while Rosetteless cells produce diverse splice isoforms. (**E**) Wild-type cDNA yielded the expected splice isoform (i) while Rosetteless mutant cDNA yielded isoforms with: (ii) intron 7 retention or (iii--iv) variants of exon 7 that were longer (\*) or shorter (\*\*) than wild type. Isoforms ii and iv contained early stop codons (arrows). (**F**) Semi-quantitative analysis of the fluorescent signal observed in Rtls dot blots, normalized to the intensity of the wild-type culture (WT). Rosetteless mutant cells (*rtls*^*l1*^) showed reduced Rtls signal both with and without *A. machipongonensis* (*Alg*) relative to WT ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). Error bars show standard deviation.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.014](10.7554/eLife.04070.014)10.7554/eLife.04070.015Figure 5---figure supplement 1.Rosetteless splicing and protein levels.(**A**) RT-PCR with a primer bridging the exon 7/8 boundary of *rtls* paired with a primer in exon 12, amplified the wild-type *rtls* splice isoform from wild-type and *rtls*^*l1*^ cDNA. This was in contrast with the diverse alternative *rtls* splice isoforms amplified from Rosetteless cells when RT-PCR was performed with a primer bridging the exon 5/6 junction and a primer in exon 12 ([Figure 5D](#fig5){ref-type="fig"}). (**B**) Purified, recombinant protein corresponding to the anti-Rtls epitope has a predicted size of approximately 38 kDa (arrowhead). The purity of 100 ng of recombinant protein was analyzed by silver stain (left) and by western blot with anti-Rtls (right) on two separate 4--12% gradient gels. (**C**) Raw data showing the validation of anti-Rtls on dot blots of wild-type cell lysates. Pre-incubation of anti-Rtls with the recombinant Rtls epitope competes away the staining, demonstrating that the majority of the signal is specific to the Rtls protein. Three replicate samples are shown. (**D**) Raw dot blot data showing levels of Rtls in wild-type (WT) or Rosetteless mutant (*rtls*^*l1*^) cultures with or without inoculation with *A. machipongonensis* (*Alg*.). Each spot is normalized for total *S. rosetta* cell number.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.015](10.7554/eLife.04070.015)10.7554/eLife.04070.016Figure 5---figure supplement 2.The diversity of *S. rosetta* and *M. brevicollis* CTLD-containing proteins.The protein domain architectures of all CTLD-containing proteins predicted in the genomes of *S. rosetta* (blue) and *M. brevicollis* (purple) are shown. In addition, diagrams of select animal CTLD-containing proteins with similar architectures to Rosetteless are provided (white). Genbank accession numbers are listed at the left. All diagrams are drawn to scale. Although proteins in choanoflagellates are commonly assigned animal orthologs based on their diagnostic domain architecture, the minimal domain features of Rosetteless preclude any clear assignments of orthology. Additionally, within animals, C-type lectins are a family of rapidly evolving genes that exhibit extensive duplications and rearrangements among taxa (e.g., \[[@bib16]\], \[[@bib52]\]). It is thus not currently possible to assign clear orthology relationships between many of the animal C-type lectins, much less between animal C-type lectins and more evolutionarily distant CTLD-containing proteins found in choanoflagellates and other eukaryotes (e.g., \[[@bib60]\]).**DOI:** [http://dx.doi.org/10.7554/eLife.04070.016](10.7554/eLife.04070.016)

We hypothesized that the exon 7 splice donor mutation in Rosetteless cells might result in defective splicing of *rtls*. To test whether proper *rtls* splicing of exons 7 and 8 can occur in Rosetteless cells, we performed RT-PCR using primers that selectively amplify *rtls* splice isoforms with the predicted exon 7/8 junction and recovered the expected splice isoform from both wild-type and Rosetteless cells ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}, [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). However, when using primers that could amplify either the wild-type isoform or variant splice isoforms (a 5′ primer bridging the exon 5/6 junction paired with a 3′ primer in exon 12), we found that *rtls* was spliced as predicted in wild-type cells, but produced multiple, variant splice isoforms in Rosetteless cells. The variant isoforms included one isoform in which intron 7 was retained and two smaller isoforms in which an alternative splice donor either 14 bp upstream or 27 bp downstream of the mutation was used instead ([Figure 5D,E](#fig5){ref-type="fig"}). Importantly, the wild-type *rtls* isoform was not detected in Rosetteless cells using this assay. For two of the major splice isoforms in Rosetteless cells, the altered splicing led to frame shifts and early stop codons downstream of the mutation, which may either lead to a truncation of the Rtls protein or to degradation of the transcript by nonsense mediated decay in mutant cells ([@bib30]). To investigate endogenous Rtls protein in *S. rosetta* cells, we generated an antibody against residues 438--539, a region of the protein that is unique to Rtls and expected to be present in all wild-type and mutant Rtls isoforms ([Figure 5A](#fig5){ref-type="fig"}, 'Materials and methods'). Using this antibody, we found that total Rtls protein levels in mutant cells were ∼25% that of wild-type cells ([Figure 5F](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1B--D](#fig5s1){ref-type="fig"}).

The lack of transgenic approaches in choanoflagellates meant that we could not complement the *rtls*^*l1*^ mutation nor delete the *rtls* gene in wild-type cells. Nonetheless, C-type lectins in animals have been functionally perturbed through the use of blocking antibodies ([@bib59]; [@bib35]), and we hypothesized that we could block the function of the extracellular pool of Rtls protein by incubating wild-type cells with an anti-Rtls antibody ('Materials and methods'). Therefore, to test the necessity of Rtls function for rosette development, wild-type *S. rosetta* cultures were incubated with 0--50 μg/ml anti-Rtls antibody during exposure to *A. machipongonensis* bacteria. Treatment with anti-Rtls resulted in significant inhibition of rosette formation relative to negative controls ([Figure 6A](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). Specifically, in cultures treated with 50 µg/ml anti-Rtls during rosette induction, only 10 ± 11% of cells were observed in rosettes (mean ± standard deviation, [Figure 6A](#fig6){ref-type="fig"}). In contrast, wild-type *S. rosetta* cultures incubated with an equal volume of rabbit pre-immune serum or an equivalent concentration of normal rabbit IgG or BSA showed normal levels of rosette development, with 91 ± 2%, 90 ± 2%, or 88 ± 1% of cells in rosettes, respectively. Importantly, treatment of wild-type cells with 50 µg/ml anti-Rtls did not result in a loss of cell viability or reduction in cell growth ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). Therefore, we conclude that the function of secreted Rtls is specific to and essential for rosette development.10.7554/eLife.04070.017Figure 6.Rtls is required for rosette development and localizes to the center of rosettes.(**A**) Rosette development in wild-type *S. rosetta* was inhibited in the presence of 50 µg/ml anti-Rtls antibody, leading to a significant reduction in the percentage of cells in rosettes (one-tailed *t* test, p \< 0.05) as compared to BSA, pre-immune serum, and IgG negative controls. Error bars show standard deviation. (**B**--**C**) The localization pattern of cell-associated Rtls differs between wild-type rosettes, chains, and single cells. (**B**) In rosettes, Rtls (cyan) was detected as a thick layer associated with the basal poles of the cells. Commonly, a gap was observed in the Rtls staining between one pair of neighboring cells in each rosette (arrow). The collar microvilli and filopodia were stained with phalloidin (red) and anti-tubulin staining (white) was used to highlight the cell body and flagellum. (**C**) Rtls localization in (1) wild-type rosettes, (2) wild-type chains, (3) wild-type single cells, and (4) Rosetteless mutant single cells. In single cells and chains imaged as in [Figure 6B](#fig6){ref-type="fig"} ('Rtls', laser intensity = 2.0, zoom = 2.5, gain = 544), Rtls signal was nearly undetectable. However, when imaged with a higher photomultiplier gain ('Rtls--high gain', laser intensity = 2.0, zoom = 2.5, gain = 750), Rtls was detected in membrane-associated patches (arrowheads) in wild-type single cells and chains, but not in Rosetteless cells. Wild-type single cells and chains frequently also had immunoreactive material deposited on the slide adjacent to the cells (asterisk). All cell types showed faint, diffuse fluorescence throughout the cell body, but this was likely the result of non-specific staining ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). Scale bars = 5 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.017](10.7554/eLife.04070.017)10.7554/eLife.04070.018Figure 6---figure supplement 1.Anti-Rtls blocks rosette development.(**A**) Extended data for [Figure 6A](#fig6){ref-type="fig"}, showing that increasing concentrations of anti-Rtls lead to a significant reduction in rosette development relative to BSA, IgG, and pre-immune serum negative controls. (**B**) Cell densities of wild-type *S. rosetta* incubated with 50 μg/ml BSA, pre-immune serum, 50 μg/ml IgG, or increasing concentrations of anti-Rtls for 24 hr for the experiment in (**A**), demonstrating that the reduction in rosette development following treatment with anti-Rtls was not due to growth inhibition.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.018](10.7554/eLife.04070.018)10.7554/eLife.04070.019Figure 6---figure supplement 2.Validation of the anti-Rtls antibody in immunofluorescence.To determine the specificity of the anti-Rtls antibody, the antibody was incubated either with (+) or without (−) the recombinant, purified epitope prior to the staining of wild-type or Rosetteless mutant cells. This pre-incubation of anti-Rtls with its purified epitope was expected to compete away the specific anti-Rtls signal and led to the loss of: the bright staining in the center of rosettes, the enriched patches of staining associated with the cell membranes of wild-type single cells (arrowhead), and immunoreactive material that was often detected on the slide surface adjacent to wild-type single cells (\*). Notably, these are also the staining patterns that are missing from the Rosetteless mutant cells. (The loop at the apical tip of the flagellum was observed in wild-type and mutant cells and is not part of the Rosetteless phenotype.) In all cells following competition with the epitope there remained faint staining in the cell body; we thus infer that this is non-specific staining that does not reflect the distribution of Rtls protein in the cells. All cells were stained with the same concentration of anti-Rtls antibody and were imaged at the same exposures by confocal microscopy. Co-staining with phalloidin (red) and anti-tubulin (white) allowed for the visualization of the collar, cell body, and flagellum. Scale bar = 5 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.04070.019](10.7554/eLife.04070.019)

Rtls localizes to the center of rosettes {#s2-4}
----------------------------------------

The connection between Rtls function and rosette development was also reflected in its differential localization in wild-type rosettes, chains, and single cells. In wild-type cells, Rtls was highly enriched in the extracellular matrix-filled center of rosettes, where it was observed in a thick layer underlying the basal poles of all cells in the rosette ([Figure 6B,C](#fig6){ref-type="fig"}). While Rtls staining sometimes connected all cells in the center of rosettes ([Figure 6C](#fig6){ref-type="fig"}), in most instances Rtls was observed to connect all but one pair of neighboring cells ([Figure 6B](#fig6){ref-type="fig"}). Because rosettes form through a process of incomplete cytokinesis ([@bib18]; [@bib14]), this discontinuous Rtls staining may reflect the history of cell division during rosette formation, with discontinuities in its distribution indicating adjacent cells that were not sisters. We hypothesize that Rtls regulates rosette development by interacting with components of the extracellular matrix (ECM), which has previously been shown to fill the center of rosettes ([@bib14]).

In wild-type single cells and chain colonies, the subcellular localization and apparent abundance of Rtls were notably different than in rosettes. Despite the fact that equivalent levels of Rtls were detected in lysates from rosette-induced and -uninduced cultures ([Figure 5F](#fig5){ref-type="fig"}), little to no Rtls signal was detected by immunofluorescence when wild-type single cells and chains were imaged with the settings used for visualizing Rtls in rosettes ([Figure 6C](#fig6){ref-type="fig"}). Because Rtls has a predicted secretion signal, it is possible that *S. rosetta* chain colonies and single cells released Rtls into their aquatic environment, where it may have been washed away during processing of cells for immunofluorescence. After increasing the gain used during confocal imaging, we were able to detect Rtls in cell membrane-associated patches in wild-type single cells and chains, but these patches were absent from Rosetteless mutant cells ([Figure 6C](#fig6){ref-type="fig"}, [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). The patches of Rtls localization were most often located near the basal pole of each cell, but were sometimes detected at the apical pole or along the lateral regions of the cell ([Figure 6C](#fig6){ref-type="fig"}). In no case was the Rtls staining in single cells or chains as intense as the Rtls staining observed in the cores of rosettes.

In summary, three findings demonstrate that Rtls function is necessary for and specific to rosette development: (1) the localization of Rtls protein is developmentally regulated and most abundant in the core of rosettes, (2) Rosetteless mutant cells fail to form rosettes but are otherwise wild type, and (3) secreted Rtls protein is essential for rosette development, while being dispensable during other stages of the *S. rosetta* life history.

Discussion {#s3}
==========

The *rosetteless* gene is the only gene yet known to be required for choanoflagellate multicellular development. The molecular mechanisms by which Rtls regulates rosette formation remain unknown, but the developmentally regulated secretion of Rtls protein into the ECM-filled space in the center of rosettes ([Figure 6B](#fig6){ref-type="fig"}) likely provides some important clues. Rtls may stabilize the connections between rosette cells by interacting with the ECM in a manner akin to the lecticans, a family of animal C-type lectins that stabilize cartilage and other connective tissues by cross-linking carbohydrates and proteins in the ECM ([@bib51]). Such a role would be consistent with the observation that the Rosetteless mutant produces wild-type chain colonies, as one of the main differences between rosettes and chain colonies lies in the stability and mechanical robustness of rosettes as compared to chain colonies. A second possible hint regarding Rtls function stems from the fact that the Rtls CTLDs most closely resemble animal CTLDs that preferentially bind mannose ([@bib17]), such as mannose binding protein and pulmonary surfactant protein A, each of which functions in innate immunity as pattern recognition receptors ([@bib58]). Because rosette development is regulated by bacterial signals ([@bib4]), Rtls may play a role in substrate recognition and cell signaling. Future work on the biochemical and physiological roles of Rtls will enable the discovery of other proteins in the rosette development regulatory pathway, while also potentially providing insights into the ancestral functions of CTLD-containing proteins.

The discovery that Rosetteless regulates rosette development provides a starting point for investigating the relationship between animal and choanoflagellate multicellularity. CTLD-containing proteins have previously been shown to regulate cell adhesion and development in animals ([@bib48]; [@bib24]; [@bib28]; [@bib13]), offering intriguing parallels with the role of the Rosetteless CTLD protein in the control of rosette development. However, the molecular functions of Rtls are currently unknown and it is therefore unclear whether they are conserved in animal CTLD-containing proteins. Moreover, while the genomes of diverse animals encode Rtls-like proteins containing a signal peptide, two C-type lectin-like domains, and serine-threonine-rich low complexity regions (e.g., the placozoan *Trichoplax adhaerans* (XP_002112548), the cnidarian *Hydra vulgaris* (XP_002155329), the nematode *Caenorhabditis elegans* (NP_501369.1), and the fish *Danio rerio* (XP_005158004); relevant motifs detected by SMART, \[[@bib31]\]), it is not clear whether the similarities among these proteins and Rtls are the result of homology or convergent evolution ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Although it is not straightforward to reconstruct the evolutionary relationships among *S. rosetta* and animal CTLD-proteins, the future analysis of additional rosette defect mutants promises to illuminate the remaining rosette regulatory pathway and reveal whether this pathway is conserved in the regulation of animal multicellularity.

Forward genetic screens have been vital tools for uncovering fundamental mechanisms driving development in eukaryotic model organisms, including *Saccharomyces cerevisiae, Drosophila melanogaster*, *C. elegans*, *Mus musculus*, *D. rerio*, and *Arabidopsis thaliana* ([@bib23]; [@bib8]; [@bib45]; [@bib38]; [@bib22]; [@bib25]), but such approaches have been restricted to a relatively small number of taxa that represent a small fraction of eukaryotic diversity ([@bib2]). Expanding the phylogenetic reach of forward genetic approaches will allow for a more rigorous and complete interrogation of the origin and evolution of animal development. The establishment of forward genetics in choanoflagellates has provided the first insights into the genetic underpinnings of development in these evolutionarily relevant organisms and promises to illuminate mechanisms underlying intercellular interactions in the progenitors of animals.

Materials and methods {#s4}
=====================

Culture media {#s4-1}
-------------

Unenriched artificial seawater (ASW), cereal grass media (CG media), and high nutrient (HN) media were prepared as described previously ([@bib32]). HN media (250 mg/l peptone, 150 mg/l yeast extract, 150 µl/l glycerol in unenriched sea water) was made by diluting Sea Water Complete Media ([@bib6]) to 5% (vol/vol) in ASW*. A. machipongonensis* conditioned media (ACM) was made from the sterile supernatant of the liquid *A. machipongonensis* culture (ATCC BAA-2233 \[[@bib5]\]) grown shaking for 48 hr in HN media at 30°C to an OD~600~ of 0.30--0.39 and filtered through a 0.2 µm filter to remove bacterial cells and detritus.

The above conditions were used for the isolation of all mutants except Rosetteless. For this mutant, ACM was prepared in CG media and was grown for 24 hr to an OD~600~ of 0.1. Rosetteless clonal isolation steps used a mixture of 20% *Algoriphagus* conditioned CG media, 5% fresh CG media, and 75% ASW (vol/vol).

Strains {#s4-2}
-------

The parental strain for the screen was SrEpac (ATCC PRA-390; accession number SRX365844), which contains *S. rosetta* grown in the presence of *Echinicola pacifica* bacteria ([@bib41]; [@bib32]), previously described as 'Isolate C' in [@bib32]. SrEpac was generated through serial clonal isolation to ensure a genetically homogeneous background for the screen, and frozen stocks of SrEpac were thawed prior to each mutagenesis to limit the accumulation of random mutations. SrEpac cultures were haploid when passaged every 2--3 days in HN media ([@bib32]). During each mutagenesis treatment, an SrEpac culture was divided into two; one half was mutagenized and the other half underwent all incubations, washes, and clonal isolation steps of the protocol except for the mutagenesis.

The Isolate B culture used in the cross (accession number SRX365839) contains *S. rosetta* grown in the presence of *A. machipongonensis* bacteria. Isolate B was diploid when passaged with scraping every 3 days in CG media ([@bib32]).

Mutagenesis {#s4-3}
-----------

To determine a mutagen dose to be used in the screen, we titrated each mutagen over three orders of magnitude and examined the cell number of mutagenized vs unmutagenized cultures 24 hr later ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). For both EMS and X-rays, we observed a general decrease in cell number following increased mutagen dose, suggesting that the mutagen was effective. For the screen, we used mutagen doses of 0.3% (vol/vol) EMS and 6300 rem of X-rays, as both treatments showed an intermediate effect on cell number, but this effect varied considerably among mutagenesis trials.

For EMS mutagenesis, approximately 10^6^ cells were washed and resuspended in 1 ml ASW. Liquid EMS (ethyl methanesulfonate, Sigma, St. Louis, MO) was added to 0.3% (vol/vol) and cells were incubated 1 hr at room temperature. The EMS was subsequently removed and neutralized by washing the cells three times in 5% sodium thiosulfate in ASW (wt/vol) before returning the cells to their initial media (HN or CG media) for 24 hr of recovery. In parallel with the isolation of the Rosetteless mutant, we also co-isolated a wild-type strain (C2E5) that underwent all washing and clonal isolation steps but was not mutagenized.

Fox X-ray mutagenesis, approximately 10^6^ cells were transferred into 35 mm diameter tissue culture dishes (Thomas Scientific, Swedesboro, NJ) and placed in an X-ray cabinet (Faxitron 43855C) 30.3 cm from the X-ray source with the lids of the dishes removed. Cultures were irradiated at the 125 V, 3 mA setting for 3 hr, which corresponded to a dose of approximately 6300 rems. Although we observed only mild choanoflagellate death from the mutagenesis treatments ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}), there was significant death and/or growth inhibition of the *E. pacifica* bacteria following X-ray mutagenesis. Therefore, to avoid *S. rosetta* starvation, we added 500 µl of an unmutagenized, liquid culture of *E. pacifica* bacteria to the *S. rosetta* after X-ray mutagenesis and resuspended the cells in 10 ml HN media before a 24 hr recovery.

To measure the X-ray dose delivered under these conditions, we placed ring dosimeters at the same position and exposed them for 1 min, 1.5 min, or 1.75 min to generate a standard curve. By linear regression, we obtained the following formula with a fit of R^2^ = 0.997: millirems of exposure = 35,091 \* (minutes exposure)---4531.1. Given this equation, we calculated that the X-ray mutagenesis dose corresponded to approximately 6300 rems.

Screen for rosette defect mutants {#s4-4}
---------------------------------

SrEpac cells were mutagenized either with 0.3% (vol/vol) liquid EMS (ethyl methanesulfonate) for 1 hr or exposed to 6300 rem of X-rays ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). 24 hr after mutagenesis, control and mutant clones were isolated by dilution-to-extinction into 150 µl screen media (20% ACM, 40% HN media, 40% ASW \[vol/vol\]) in 96-well plates. Cells were plated at an approximate density of 1 cell/150 µl (i.e., 1 cell/well). The probability that each isolate underwent a clonal bottleneck during this step was 0.70 to 0.89, calculated using the Poisson distribution and the number of choanoflagellate-free wells per plate ([@bib32]). After 5--7 days, clonal populations were visually screened for mutants deficient in rosette formation ([Figure 2](#fig2){ref-type="fig"}). Selected controls and rosette defect mutants were expanded in 3 ml 10% ACM in 6-well plates to verify the phenotype.

In total, we isolated 19 candidate mutants. Nine were eventually verified as rosette defect mutants through repeated re-isolation and testing of rosette induction. A tenth mutant had a mild growth defect and was thus discarded. Of the remaining candidate mutants, most were isolated as thecate cells, a cell type that is not competent to form rosettes ([Figure 1](#fig1){ref-type="fig"}) ([@bib14]), but upon further passaging the cells in these cultures began to form rosettes. We concluded that the rosette defect phenotypes initially detected in these clones were likely a result of epigenetic rather than genetic heritability, and we focused instead on the nine verified rosette defect mutants.

To ensure that each mutant and control isolate was truly clonal, a second clonal isolation step was performed into 96-well plates to an average of 1 cell/1500 µl (i.e., 1 cell/10 wells). The probability that each isolate underwent a clonal bottleneck during this step was 0.935 to 0.997, resulting in an overall probability of 0.991--0.999 that each isolate underwent a clonal bottleneck at least once.

Quantification of mutant rosette defects ([Figure 3A](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}) {#s4-5}
--------------------------------------------------------------------------------------------------------------------------------------------

*S. rosetta* cultures were exposed to either ACM or live colony-inducing bacteria. For the live bacteria treatments, *A. machipongonensis* liquid cultures were grown shaking in HN media at 30°C for 24 hr. To begin the induction, *S. rosetta* cells were diluted to 10^4^ cells/ml in 3 ml HN media with either 20% ACM or 4 µl/ml of liquid *A. machipongonensis* culture. 48 hr after induction, we pipetted the culture vigorously and repeatedly to break up chain colonies, concentrated the cells fivefold by centrifugation, fixed an aliquot of the culture with formaldehyde, and assessed rosette formation by counting on a hemacytometer. Thus, our operational definition for rosettes only included those rosettes that were robust to vigorous pipetting.

Imaging mutant rosette phenotypes {#s4-6}
---------------------------------

For all experiments to visualize mutant rosette phenotypes, cells were plated at a density of 10^4^ cells/ml in 3 ml of either HN media or 10% ACM in HN media (vol/vol). Cultures were imaged 48 hr after induction. For all non-fluorescent images, cells were visualized live ([Figure 3B,C](#fig3){ref-type="fig"}, and [Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}).

For the high magnification DIC images ([Figure 3B,C](#fig3){ref-type="fig"}), 96-well µclear flat bottom plates (Greiner) were coated with 0.1 mg/ml poly-D-lysine (Sigma) for 5 min and allowed to air dry for 5 min before gently transferring 100 µl of culture to the well with a cut-off pipet tip. Cells were allowed to settle for 5 min and imaged live at 63× oil immersion with a Leica DMI6000B microscope equipped with a Leica X-Cite 120 camera.

To visualize low magnification fields of view of the mutants following pipetting ([Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}), cells were pipetted rigorously to break up chain colonies and concentrated 30--100-fold by centrifugation. 10 to 20 µl of concentrated cells were imaged live on a slide at 10× on a Leica DMIL LED inverted compound microscope with a Leica DFC 300FX camera.

For the confocal slices through rosette colonies ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}), sterile, 8-well µ-slides (Ibidi, Germany) were coated with 0.1 mg/ml poly-D-lysine (Sigma) for 5 min and allowed to air dry for 5 min before gently transferring 250 µl of culture to the well with a cut-off pipet tip. Cells were fluorescently stained with 1 µl of 2.5 µg/ml FM 1-43X dye (Molecular Probes, Eugene, OR), fixed with 1 µl 25% glutaraldehyde (Electron Microscopy Sciences, Hatfield, PA), allowed to settle for 5 min, and imaged at 63× using a Zeiss LSM 700 confocal microscope. Single confocal slices are shown.

Imaging mutant chain phenotypes ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}) {#s4-7}
-------------------------------------------------------------------------------------------

Because chain colonies break up upon pipetting and because some of the mutants formed chains with very large clusters of cells, we attempted to visualize the chain phenotypes while manipulating the cells as little as possible. Cells were diluted at a 1:10 ratio into 10 ml of HN media in 25 cm^2^ culture flasks (Corning, NY). 24 hr later, we imaged the chain colonies at the bottom of the flask at 10× using a Leica DMIL LED inverted compound microscope with a Leica DFC 300FX camera. Images were manually false colored to highlight the chain colonies that were in focus.

Genome sequencing {#s4-8}
-----------------

We sequenced the genomes of the Rosetteless mutant, the parental strain from which it was derived, and an unmutagenized wild-type strain (C2E5) that was isolated and cultured in parallel with Rosetteless. We prepared genomic DNA from mutant and wild-type *S. rosetta* cultures by phenol chloroform extraction and used a CsCl gradient to separate *S. rosetta* and *E. pacifica* DNA by GC content ([@bib27]). Multiplexed, 100 bp paired-end libraries were sequenced on an Illumina HiSeq 2000. Raw reads were trimmed with TrimmomaticPE ([@bib36]) to remove low quality base calls. Trimmed reads were mapped to the *S. rosetta* reference genome ([@bib19]) using Burrows-Wheeler Aligner ([@bib33]), and we removed PCR duplicates with Picard (<http://picard.sourceforge.net>). Rosetteless was sequenced to a median coverage of 71× and over 93% of the reference genome had at least 10× coverage, while the parental strain and C2E5 were each sequenced to a median coverage of 50--60× and over 91% of the genome had at least 10× coverage. We realigned reads surrounding indel calls using GATK ([@bib15]) and called variants using SAMtools and bcftools ([@bib34]). To obtain the high quality variant calls ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), we removed all variants that were called with a quality score below 100 in addition to all variants that were called as heterozygous, since we expected these haploid genomes to yield homozygous calls. We focused on detecting single nucleotide variants (SNVs), because Rosetteless was isolated following EMS treatment.

Identifying Rosetteless SNVs {#s4-9}
----------------------------

After filtering the detected SNVs by quality score, we found that Rosetteless contained 25,160 high-quality SNVs, 25,143 of which (99.93%) were shared among Rosetteless and at least one of the wild-type strains (the parental strain and C2E5), meaning that they were segregating polymorphisms, which were unlikely to contribute to the Rosetteless phenotype. We experimentally validated all of the predicted Rosetteless-specific SNVs ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Short regions of genomic DNA flanking SNVs predicted to be unique to Rosetteless were amplified by PCR using a 1:1 mix of Taq (New England Biosciences, Ipswich, MA) and Pfu (Thermo Fisher Scientific, Waltham, MA), gel extracted using the GeneClean II kit (MP Biomedicals, Santa Ana, CA), and analyzed by Sanger sequencing. SNVs were considered 'verified' if they were present in Rosetteless gDNA but absent from gDNA from the parental strain. The supercontig 8 splice donor mutation (*rtls*^*l1*^) was the only Rosetteless-specific SNV predicted to alter a coding region, and we confirmed that this mutation was present in Rosetteless and absent from the parental strain by PCR and Sanger sequencing ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). In contrast, when we attempted to verify the other 16 detected Rosetteless SNVs, only three were verified as polymorphic between Rosetteless and the parental strain. Of the remaining variants, three were false-positive variant calls in Rosetteless, two lay within regions of the reference genome that were misassembled, and eight were false-negative variant calls, where shared, segregating polymorphisms were not identified in the parental strain or the C2E5 wild-type strain. Thus despite the fact that the vast majority of called SNVs were high quality and independently called in all three samples, the enrichment of poor SNV calls in the Rosetteless-specific set meant that of the 17 potentially unique SNVs originally identified in the Rosetteless genome, there remained only four verified SNVs, including a predicted splice donor mutation at supercontig 8: position 427,804.

We were initially surprised to find such a small number of unique mutations in Rosetteless. However, it is possible that the EMS mutagenesis was ineffective prior to the isolation of Rosetteless, which is consistent with the fact that the Rosetteless mutagenesis did not result in substantial cell death ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). Thus, despite the fact that Rosetteless was derived from a culture treated with EMS, it may in fact be a spontaneous mutant.

The raw reads for the SrEpac parental strain, the C2E5 wild-type co-isolate, and Rosetteless are publicly available (accession numbers SRX365844, SRX476076, and SRX476075, respectively). All alignments of protein sequences were made using fast statistical alignment ([@bib7]).

Validating and genotyping additional SNVs {#s4-10}
-----------------------------------------

To investigate whether additional mutants isolated in this screen (i.e., mutant classes B--G; [Table 1](#tbl1){ref-type="table"}) bore mutations in *rtls*, we used Phusion polymerase (New England Biosciences) to amplify the coding region of the *rtls* from each mutant prior to cloning into the pCR 2.1 vector (Invitrogen). The coding region was divided into three regions for each mutant, using the following primer pairs: Rtls_L1/Rtls_R3, Rtls_L5/Rtls_R4, and Rtls_L3/Rtls_R2 ([Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). The full insert of each clone was analyzed by Sanger sequencing. No mutations were found in *rtls* in any of the eight remaining rosette defect mutants.

To genotype microsatellites with size polymorphisms larger than 30 bp (e.g., the indel1 marker), we separated PCR products on a 2% agarose gel. To genotype smaller microsatellites, we fluorescently labeled PCR products ([@bib54]) and analyzed the size polymorphisms by fragment analysis on a 3730XL DNA Analyzer (Applied Biosystems). The gt_indel_2 and gt_indel_7 primer sets included an M13 site on the left primer to enable fluorescent labeling in a 3-primer reaction, while the gt_indel_9 left primer was directly fluorescently labeled ([Supplementary file 1](#SD2-data){ref-type="supplementary-material"}).

Performing a choanoflagellate cross {#s4-11}
-----------------------------------

### Part 1: isolation of a haploid strain of isolate B {#s4-11-1}

As Rosetteless and its SrEpac parental strain had very few genetic differences that could be tracked in a backcross ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), we opted instead to perform a cross between the Rosetteless mutant and Isolate B, which was previously sequenced ([@bib32]) and was predicted to have 39,451 polymorphic markers relative to Rosetteless ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Isolate B had been maintained as a diploid culture, which was not suitable for crossing to the haploid Rosetteless strain. However, as Isolate B exhibited genome-wide homozygosity, we reasoned that if we could induce Isolate B to undergo meiosis and generate an Isolate B haploid strain, this haploid strain would inherit the same predicted markers as the sequenced, diploid Isolate B strain. Thus, our first goal was to isolate a haploid strain from Isolate B.

Isolate B consists of *S. rosetta* cells that are fed *A. machipongonensis* bacteria and cultivated in CG media ([@bib32]). We induced Isolate B to become haploid by passaging the culture with a 1:2 or 1:5 dilution every 2 to 3 days in CG media for several weeks. Although Isolate B is typically thecate when diploid, this passaging regime resulted in a culture consisting mostly of rosettes. We measured the ploidy of the culture by flow cytometry as in [@bib32] and found that approximately 51% of the population was haploid. To establish a clonal, haploid line of Isolate B, we isolated cells by limiting dilution into 96-well plates containing 10% CG media in ASW. The probability of clonal isolation during this step was 0.93. We selected 12 isolates to expand into larger volumes and measured the ploidy of each clonal population by flow cytometry. We selected one isolate that consisted almost entirely of haploid cells to proceed.

### Part 2: induction of mating {#s4-11-2}

Our next goal was to induce mating between Rosetteless and the haploid Isolate B culture. *S. rosetta* mating can be induced by transferring a stationary phase culture to nutrient poor media for several days ([@bib32]). As *S. rosetta* can undergo both self-fertilization and outcrossed mating ([@bib32]), we expected this procedure would generate a mixed population of cells that would include: (1) outcrossed heterozygous diploids containing both mutant and wild-type alleles, (2) homozygous diploids generated from the self-fertilization of either parental type, and (3) haploid, parental-type cells that never underwent mating. For the purposes of the cross, we were interested in only the outcrossed, heterozygous diploids. To enrich for these cells, we needed to both maximize the proportion of the population that was induced to mate and attempt to have an equal mix of Rosetteless and Isolate B cells present when mating occurred.

We first attempted to grow the Rosetteless and Isolate B cultures at similar rates through similar passaging regimes. The *S. rosetta* in Rosetteless and Isolate B are cultured with two different species of bacteria, so we added 1 ml of an *A. machipongonensis* liquid culture to Rosetteless and 1 ml of an *E. pacifica* liquid culture to Isolate B to ensure that both choanoflagellate cultures were fed to both bacterial species. The two isolates were passaged daily for 8 days to a starting cell density of 5 × 10^4^ cells/ml in 10 ml CG media. This was continued for 8 days. On the first 2 days, 1 ml of liquid *E. pacifica* culture in HN media was added to each isolate to encourage rapid growth.

On the ninth day, we set up the starvation conditions for the cross. We mixed the cells together by adding 5 × 10^5^ cells from each culture to 9 ml CG media and 1 ml of liquid *E. pacifica* culture. The next day, the mixed culture was pelleted and resuspended in 10 ml ASW to starve the cells and induce mating ([@bib32]). After 11 days of starvation in ASW, we measured the ploidy of the culture and found that approximately 75% of the cell population had become diploid, suggesting that mating had occurred. 3 ml of the starved culture was then added into 10 ml CG media and cells were subsequently passaged every 1--3 days for 8 days to revive the cultures from their starved state.

### Part 3: identification of outcrossed diploids {#s4-11-3}

Following mating, we isolated clones and identified cells that had undergone outcrossed mating through genotyping. We reasoned that genotyping each clone at three unlinked markers could provide evidence for meiosis through independent assortment, while also allowing for multiple, genetically distinct, progeny to be isolated from each flask. Because the chromosome number of *S. rosetta* has not been determined, we selected three markers, each on one of the three largest assembled supercontigs (2.5 Mb, 2.0 Mb, and 1.9 Mb in size), to help ensure that the markers would either be on different chromosomes or far enough apart to be unlinked.

We isolated clones by limiting dilution into twenty 96-well plates containing 10% CG media in ASW (vol/vol). The probability of clonal isolation in this step was 0.86. After 1 week of growth, 384 isolates were expanded into 4 ml 50% CG media in 6-well plates to accumulate enough biomass for genotyping. After 4--7 days growth, we pelleted 2 ml of the culture and extracted DNA using a base/Tris method as follows. We resuspended the pellet in 20 µl base solution (25 mM NaOH, 2 mM EDTA), transferred the sample into PCR plates, and boiled at 100°C for 20 min, followed by cooling at 4°C for 5 min. We then added 20 µl Tris solution (40 mM Tris--HCl, pH 7.5) and used 1 µl of this sample as the DNA template for each of our genotyping reactions.

To identify which clonal populations were the result of outcrossed mating (as opposed to self-mating), we genotyped each of the clonal isolates at three microsatellite markers that were polymorphic between the Rosetteless and Isolate B parental strains (gt_indel_2, gt_indel_7, and gt_indel_9; [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}). Any clonal populations that had undergone outcrossed mating were expected to be heterozygous at all three markers, while those that did not mate or self-fertilized were expected to be homozygous at all three markers. Of the 384 genotyped clones, seven were heterozygous at all three markers, suggesting that these clones were the product of outcrossed mating. All remaining clones were homozygous at all three markers, but 372 clones were homozygous for the Isolate B alleles, while only three were homozygous for the Rosetteless alleles, raising the possibility that the Rosetteless mutant was less viable than Isolate B under the starvation conditions used to induce mating. Such differential viability may also explain the low rate of outcrossed mating, if few Rosetteless haploids survived to mate with Isolate B haploids. But despite the low frequency of outcrossed mating, we proceeded with the cross using the heterozygous diploids.

### Part 4: induction of meiosis and initial isolation of haploid, meiotic progeny {#s4-11-4}

We next induced meiosis in the outcrossed heterozygotes to complete the sexual life cycle and obtain recombinant, haploid progeny from the cross. We expanded the heterozygotes in 10 ml CG media and measured the ploidy of the cultures, expecting that the heterozygotes would form largely diploid population of cells. In four of the seven cultures, the population remained mostly diploid, whereas there was a substantial haploid population in the remaining three cultures, suggesting the meiosis had already occurred for a large subset of these cells. To ensure that we could isolate the products of independent meioses, we divided the four, mostly diploid cultures into ten total flasks and then passaged these cultures rapidly to induce meiosis ([@bib32]). 1 ml of liquid *E. pacifica* culture was added to each flask. The ten flasks were passaged every 1--2 days for 7 days, scraping to dislodge thecate cells and adding liquid *E. pacifica* each time.

We next repeated the clonal isolation and genotyping steps, as above, to identify the haploid products of meiosis. We genotyped 288 clonal populations and identified 32 isolates (11%) that were homozygous at all three genotyped markers. All of these putatively haploid cultures formed either rosettes or chain colonies. We also identified 17 clonal cultures that were homozygous at some markers but heterozygous at others; these apparently diploid clones were presumably generated from the products of meiosis that later underwent a second round of mating before clonal isolation. Notably, the majority of the isolates (83%) were cultures of thecate cells that were heterozygous diploids and did not undergo meiosis.

### Part 5: isolating additional haploid progeny {#s4-11-5}

Based on the genotyping results from Part 4, we hypothesized that the differentiation into the thecate cell type was a morphological correlate of diploidy. Therefore, we thawed one of the original heterozygous diploid isolates and again attempted to induce meiosis, this time while excluding the thecate cells during passaging. After thawing the heterozygous isolate into 10% CG medium (vol/vol in ASW), we scraped the culture to dislodge thecate cells and immediately divided the culture into six flasks. We passaged each flask every 2 days without scraping to induce meiosis and select against the thecate cells. We then repeated the clonal isolation and genotyping steps as above for 154 clonal isolates, of which 150 were haploid progeny (97%). Of the 182 total haploid progeny, four were duplicates of other isolates (as they shared matching genotypes at \>90% of markers), and these were excluded from further analysis. Therefore, the mapping cross described here allowed for the isolation of 178 independent haploid progeny.

Rosetteless: dominant or recessive? {#s4-12}
-----------------------------------

We sought to investigate whether the Rosetteless phenotype was dominant or recessive by examining the phenotypes of the heterozygotes isolated after mating Rosetteless to Isolate B. All seven heterozygous cultures contained predominantly thecate cells---a cell type that is not competent for rosette formation ([Figure 1](#fig1){ref-type="fig"}) ([@bib14])---and three of these cultures also contained a small number of rosettes. The presence of rosettes (and absence of chain colonies) suggested that the Rosetteless phenotype might be recessive. However, culture conditions that favor rosette or chain colony development over the production of thecate cells (i.e., rapid passaging in nutrient-rich media) also favor meiosis, meaning that the rare rosette colonies could represent a minority of cells that had already undergone meiosis. Therefore, we were not confident that rosettes were developing from diploid cells and could not definitively determine whether the Rosetteless phenotype was dominant or recessive.

Linkage map construction {#s4-13}
------------------------

From the genome sequences of Rosetteless and Isolate B, we identified 39,451 putative polymorphic positions that could be used as markers to genotype the mapping cross. We prioritized markers that were: (1) on supercontig 8 near to the 427,804 *rtls*^*l1*^ splice donor position, to increase our confidence in the mapping; (2) validated Rosetteless-specific SNVs ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}), because these were other plausible candidates for causing the Rosetteless phenotype; and (3) markers located near the ends of supercontigs, as linkage detected between these positions and markers on other supercontigs would allow for an improved linkage map of the *S. rosetta* genome.

We genotyped 182 haploid isolates at 60 markers, for a total of 10,920 genotyping reactions. In addition to the three microsatellite markers, the cross progeny were further genotyped at 57 markers using KASP technology (LGC Genomics, Beverly, MA; [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"} and [Supplementary file 2](#SD3-data){ref-type="supplementary-material"}). We obtained genotype data for 91% of these reactions. Four of the cross isolates were duplicates of other isolates in the set and were excluded from further analysis. The program R/qtl ([@bib9]) was used to construct a preliminary linkage map from the Rosetteless--Isolate B cross progeny. For each genotyping reaction, Rosetteless alleles were coded as 'A' and Isolate B alleles were coded as 'H' to emulate a backcross and allow for haploid genetics to be analyzed. We included in the linkage map the 60 markers that were genotyped in over 90 progeny and the data from the 175 non-duplicate individuals that were genotyped in at least 30 markers each. We constructed linkage groups using a maximum recombination fraction of 0.4 and a minimum LOD of 5 (i.e., 1 in 100,000 odds of linkage). Following linkage group construction by R/qtl, we used the physical linkage known from the *S. rosetta* genome assembly to manually link markers on the same supercontig into a single linkage group. The linkage map is shown in [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"} and the genotype data and linkage group assignments for each marker are available in [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}.

For 78% of the genotyped markers, we observed that each allele was present in approximately 50% of progeny, as expected from Mendel\'s Law of Segregation ([@bib39]). However, we observed some segregation distortion for 13 of the markers examined. Four of these markers had missing data for 50--80 of the genotyped progeny, suggesting that an error in calling one of the alleles may be responsible for the apparent distortion. We also observed segregation distortion for four of the supercontig 2 markers and the gt2 splice donor marker that were each genotyped in the majority of the haploid progeny. The Rosetteless phenotype and splice donor mutation were present in 82% of the isolated progeny (145/177), while the remaining progeny readily formed rosette colonies, ([Figure 4](#fig4){ref-type="fig"}). We believe this segregation distortion may be related to the Rosetteless phenotype itself. As chain colonies break up into many individual cells, it may be more likely that chain-forming cells will be selected during the clonal isolation process as compared to cells in rosettes. However, regardless of the cause of the segregation distortion, we concluded that the defect underlying the Rosetteless phenotype was tightly linked to the *rtls*^*l1*^ splice donor mutation.

RT-PCR and cloning of *rtls*^*l1*^ splice isoforms {#s4-14}
--------------------------------------------------

We isolated RNA from the SrEpac parental strain and Rosetteless using the RNAqueous kit (Life Technologies) and prepared cDNA using oligo dT primers and Superscript II Reverse Transcriptase (Invitrogen) according to the manufacturer\'s instructions. After first strand synthesis, we performed PCR using primers flanking the candidate splice donor mutation (Rtls_2L and Rtls_1R; [Supplementary file 1](#SD2-data){ref-type="supplementary-material"}) and cloned the resulting bands into the pCR 2.1 vector (Invitrogen). Splice isoforms were determined by Sanger sequencing the full insert of each clone. From Rosetteless, we sequenced 11 clones that had retained intron 7 (isoform ii), 3 clones that had a late splice donor (isoform iii), and 21 clones that had an early splice donor (isoform iv), but no clones with the wild-type isoform. We repeated the above procedure using a primer specific to the wild-type exon 7/8 boundary (Rtls_5L and Rtls_1R) and obtained a single band from both wild-type and Rosetteless cDNA, each of which corresponded to the wild-type product upon sequencing. From both wild-type and Rosetteless samples, no bands were observed from the negative control PCRs, which used RNA that was not reverse transcribed as a template.

Generation of the anti-Rtls antibody and purification of the recombinant Rtls epitope {#s4-15}
-------------------------------------------------------------------------------------

The anti-Rtls antibody was generated using Genomic Antibody Technology (SDIX, Newark DE); in which rabbits were immunized with a DNA construct corresponding to this epitope: SSTPQQFPALVLEFPTPISESDVPAIELLLQSAGLPSNNPTGSSITVQLLSSQLVYIQLAGNFEQYAGELALKALNDQLIWQAGIPIAYVPLTSVLDQIQAT. The epitope is unique to Rtls and bears no resemblance to other polypeptide sequences in *S. rosetta*; when the amino acid sequence of the epitope was used to search the full catalog of *S. rosetta* proteins (using blastp), no other protein hit the epitope with an e-value less than 20 (i.e., the other hits were not statistically significant). The antibody was affinity purified against recombinant Rtls generated by SDIX.

Separately, we cloned, expressed, and purified recombinant protein corresponding to the epitope from wild-type *S. rosetta* cDNA that was prepared with oligo dT primers as described above. We amplified the epitope using Pfu (Finnzymes) and primers Rtls_epit_L1 and Rtls_epit_R1 ([Supplementary file 1](#SD2-data){ref-type="supplementary-material"}) and cloned it into the pGEX-6P GST-fusion expression vector. Protein was expressed in BL21 *E. coli* grown overnight at 16°C, purified using glutathione Sepharose 4B beads (GE Life Sciences, Pittsburgh, PA), and eluted with 50--100 mM glutathione. Elutions from multiple experiments were pooled and concentrated using a 30K Amicon Ultra-4 filter and the buffer was exchanged for the following protein wash buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.01% Triton X-100). To visualize the purity of the recombinant Rtls epitope, 100 ng of protein was run on a 4--12% gradient SDS-PAGE gel (Bio-Rad, Hercules, CA) and silver stained with Fermentas PageSilver Silver Staining Kit (K0681) according to manufacturer\'s instructions. For western blot analysis, samples were transferred to PVDF membrane (Immobilon-FL, IPFL00010), blocked with Odyssey Blocking Buffer (Licor, 927--40,010), and probed with anti-Rtls antibody at 1:2500 followed by the secondary antibody anti-rabbit IRDye 800CW (Licor, 926--322111). The blot was imaged with the Licor Odyssey infrared imaging system.

Dot blots {#s4-16}
---------

Wild-type and Rosetteless cultures were grown for 24 hr in the presence or absence of live *A. machipongonensis* bacteria. Following filtration through a 40 µm filter to remove bacterial biofilms, 1.5 × 10^6^ cells from each culture were pelleted, resuspended in 10 µl of lysis buffer (10 mM Tris HCl pH 8, 0.1 mM EDTA pH 8, 0.5% SDS wt/vol), and spotted directly onto a nitrocellulose membrane (NitroBind, GE Osmonics, Minnetonka, MN). Spots were allowed to air dry completely before blocking in 5% milk and treatment with anti-Rtls primary antibody (1:500). Primary antibody signal was detected using an IR-dye-conjugated secondary antibody (Licor Biosciences anti-rabbit 800 nm 1:10,000) and the Odyssey Infrared Imaging System (Licor Biosciences, Lincoln, NE). To test the specificity of anti-Rtls to Rtls protein on dot blot, the primary antibody was pre-incubated with a 100-fold molar excess of purified epitope at room temperature for 1 hr before application of the primary antibody to the membrane. Images were analyzed in ImageJ ([@bib53]) as follows: a box of constant area was placed over each dot to measure the integrated density of the area. The integrated density value for the secondary only control was subtracted from each sample to eliminate the signal due to mild autofluorescence of the membrane, and then each sample was normalized to the wild-type dot. Only dots processed on the same membrane were normalized in this manner.

Blocking rosette formation with the anti-rtls antibody ([Figure 6A](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}) {#s4-17}
---------------------------------------------------------------------------------------------------------------------------------------------------------

To induce rosette development, HN media was inoculated with a single colony of live *A. machipongonensis*, vortexed, and aliquoted into a 96-well plate. Anti-Rtls antibody (1.25 mg/ml stock in PBS) was added to a final concentration of: 50, 25, 12.5, 6.25, 3.13, or 1.56 µg/ml and SrEpac wild-type cells were added to each well at a 1:5 dilution. Cells were incubated at room temperature in 100 µl total volume in a 96-well plate for 24 hr to induce rosette development, at which point cultures were vigorously pipetted and counted on a hemacytometer. Three negative control treatments were analyzed in parallel: (1) 50 µg/ml BSA (from a 1.25 mg/ml stock in PBS); (2) 14 µl of pre-immune serum (equivalent to the volume of antibody added in the 50 µg/ml condition); and (3) 50 µg/ml of a control, rabbit polyclonal antibody (from a 1.25 mg/ml stock in PBS, \#A01008, Genscript, Piscataway, NJ). All conditions were tested in triplicate.

Immunofluorescence microscopy {#s4-18}
-----------------------------

Live cells were allowed to settle for 30--60 min onto poly-L-lysine coated coverslips (BD Biosciences) and fixed in two steps: 5 min in 6% acetone followed by 10--15 min in 4% formaldehyde. Cells were stained with the anti-Rtls genomic antibody at 6.25 ng/µl (1:200), E7 anti-tubulin antibody (1:1000; Developmental Studies Hybridoma Bank), Alexa fluor 488 anti-rabbit and Alexa fluor 647 anti-mouse secondary antibodies (1:400 each; Molecular Probes), and 6 U/ml rhodamine phalloidin (Molecular Probes) before mounting in Prolong Gold antifade reagent with DAPI (Molecular Probes). To test the specificity of the antibody staining, 1 µl of anti-Rtls primary antibody was diluted in 190 µl block (1% BSA and 0.3% Triton X-100 in 100 mM PIPES pH 6.9, 1 mM EGTA, and 0.1 mM MgSO~4~) and incubated with 9 µl of either protein wash buffer (see above) or purified epitope (equivalent to approximately 18 µg or a 60-fold molar excess) for 1 hr at room temperature before application of the primary antibody to the cells. Cells were imaged at 63× using a Zeiss LSM 700 confocal microscope (laser intensity = 2.0, zoom = 2.5, Rtls low exposure gain = 544, Rtls high exposure gain = 750).

Guidelines for choanoflagellate gene naming {#s4-19}
-------------------------------------------

To date, no official rules have been established for naming choanoflagellate mutants or genes. Thus, we outline here proposed guidelines for naming choanoflagellate genes. Any genes with clear homology to named genes in other organisms should be referred to by the pre-existing name (e.g., *hsp90*). Any genes without clear homology to named genes should be given names that allude to the gene\'s function or the phenotype of the first mutant allele isolated. Before mutant genes are cloned, each mutant is given its own name, but renaming may be necessary once the causative mutation is identified. Gene names should be written in lower case and in italics. Specific mutations should be named with one letter for the last name of the first author of the publication describing the allele and one number for the order of allele isolated. Mutations are presented as an italicized superscript (e.g., *rtls*^*l1*^). Mutant names and protein names are written in upper case and non-italics. Since many three-letter abbreviations have already been used for genes in other organisms, we propose the use of four-letter abbreviations.
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The following datasets were generated:

LevinTC, GreaneyAJ, KingN, 2014,C2E5 wild type isolate gDNA sequencing,SRX476076;<http://www.ncbi.nlm.nih.gov/sra/SRX476076>,NCBI Short Read Archive.

LevinTC, GreaneyAJ, KingN, 2014,Rosetteless mutant gDNA sequencing,SRX476075;<http://www.ncbi.nlm.nih.gov/sra/SRX476075>,Publicly available at the NCBI Short Read Archive (<http://www.ncbi.nlm.nih.gov/sra>).

The following previously published datasets were used:

LevinTC and KingN, 2013,Discovery of sexual reproduction in S. rosetta, isolate C (SrEpac),SRX365844;<http://www.ncbi.nlm.nih.gov/sra/SRX365844>,Publicly available at the NCBI Short Read Archive (<http://www.ncbi.nlm.nih.gov/sra>).
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "A C-type lectin-like protein is required for development in the choanoflagellate *S. rosetta*" for consideration at *eLife*. Your article has been favorably evaluated by Janet Rossant (Senior editor), a Reviewing editor, and 3 reviewers.

The Reviewing editor and the reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

This article by Levin et al., reports the first application of genetics to the model choanoflagellate species *Salpingoeca rosetta*, a pre-metazoan model for animal development. This organism develops from a single cell form into a multi-cellular form (rosettes) in response to environmental cues from its prey bacterium. The authors recently discovered and now take advantage of an extant sexual cycle to conduct chemical and X-ray mutagenesis. Nine mutants were uncovered through painstaking ocular inspection. One, Rosetteless, was characterized in detail here. The authors took multiple approaches to define and characterize the causative mutation, including genetic linkage analysis, whole genome sequencing, and characterization of the impact of the mutation on splicing. A genetic linkage map was constructed for the first time and used to show that the mutation segregates as a single mendelian trait on supercontig 8. The authors show that the mutation alters splicing of a putative C-type lectin, and make the case that this predicted cell surface protein is the root of the genetic defect. These studies represent a tour de force development and application of genetics to a powerful pre-metazoan model system.

The general consensus is that your manuscript represents landmark work as it describes the use of genetics for the first time in this group of organisms, and provides key insights into the evolution of animal multicellularity. In essence, this manuscript reports both significant conceptual and technical advances consistent with the high standards that one has come to expect from an *eLife* paper. We recommend that the paper be accepted for publication, provided that the following concerns are satisfactorily addressed.

1\) Demonstrate antibody specificity: As the *rtls* mutation cannot be complemented, the specificity of the Rtls antibody is fundamental to the arguments of this paper. Presently, antibody specificity has not been adequately demonstrated. For example, three key pieces of data rely on antibody specificity; Rtls antibody inhibition experiment, Rtls quantification in WT +/- bacteria media, and protein quantification in *rtls* mutants.

While the data are compelling that the antibody is recognizing the protein, one could take a skeptical view that since a Western blot is not shown recognizing a single protein of the correct mass in wild-type, and missing or truncated in mutants, that they may have simply generated an antibody that happens to bind the outside of Choanoflagellates inhibiting their cell-cell interaction, but not due to inhibiting the activity of Rtls. Demonstrating antibody specificity by Western blotting is required and is missing.

Related to this issue is the use of dot-blots for quantification. While these assays can be informative, they have significant limitations, especially regarding epiptope availability, uneven antibody adhesion, and uneven binding to the substrate. As such, they are generally not regarded as the best way to quantify the amount of protein in a sample. Rather, the standard is to perform Western blot analysis and use densitometry to quantify the amount of protein in the desired band. In combination with the lack of antibody specificity, the authors cannot be sure what the differences in intensity in the dot blots are the result of.

This manifests in the curious results of [Figure 5F](#fig5){ref-type="fig"}, which appears to have Rtls protein. However, the authors report earlier that they cannot detect appreciable amounts of properly spliced Rtls mRNA. However, [Figure 5F](#fig5){ref-type="fig"} shows that *rtls* mutants have ∼40% of the normal amount of protein. Is this due to truncated protein? Is their antibody not specific? Without a Western blot it is impossible to know what is actually being quantified. The authors do demonstrate that recombinant protein competes the antibody signal, but this raises a further question: what is the purity of the recombinant protein? A simple silver stained gel of the protein in the supplement would be informative, and again is typically reported when someone is reporting on the use of recombinant proteins.

In order to do this experiment correctly, [Figure 5-figure supplement 1 B and C](#fig5s1){ref-type="fig"} should be western blots with recombinant protein, whole cell lysates from WT, WT Alg, *rtls* and *rtls* + Alg. Parallel blots should be probed with both the pre-immune and immune sera.

2\) Homology of Rtls to metazoan proteins: The reviewers wish to understand whether Rtls is a multicellularity gene, or whether it is specific for rosette development. Although knowledge of the homology or Rtls to metazoan protein is not absolutely necessary and will probably not change the current conclusions, the relative importance of the finding reported (the mutant *rtls*) changes depending on whether Rtls is homologous or not to animal CTLD-containing proteins. Thus, if Rtls happens to be homologous to animal C-type lectins, then this will be a clear example of co-option (of adhesion proteins/domains) taken place at the origin of the metazoan lineage. If it is not, the finding is mostly important to understand the specific development of choanoflagellate colonies. Either way the finding is important enough, but the wider implications change. Thus, this issue should be clarified in order for the reader to fully grasp the implications of the findings here reported. One option is to perform phylogenetic trees to see whether Rtls (or the Rtls CTLDs) is/are homologous to metazoan C-type lectin containing genes. If trees are not possible, maybe the authors could try blast similarity network analyses. At a minimum, the authors should consider expanding the discussion to include: 1) whether *S. rosetta* or other choanoflagellates have other types of C-type lectins, 2) whether Rtls is also present in the non-colonial choanoflagellate *M. brevicollis* (from which genome is available), 3) whether CTLDs are specific to animals and choanoflagellates or are they present in other more ancient eukaryotes.
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Author response

1\) Demonstrate antibody specificity \[...\]

2\) Homology of Rtls to metazoan proteins \[...\]

We start by addressing the generation and specificity of the Rosetteless antibody. As requested, we have revised the text (described in detail below) to more clearly explain the nature of the Rosetteless antibody and the evidence for its specificity. In addition, we have added two new pieces of data: (1) a silver-stained gel documenting the purity of the recombinant Rosetteless used to compete with endogenous Rosetteless in tests of antibody specificity and (2) a Western showing that Rosetteless antibody recognizes the recombinant protein ([Figure 5--figure supplement 1B](#fig5s1){ref-type="fig"}).

First, we wish to clarify some information on the design and generation of the antibody. The Rosetteless antibody was raised against an epitope that we predicted should be present in all wild type and mutant Rtls isoforms ([Figure 5A](#fig5){ref-type="fig"}; orange bracket). Therefore, our measurements of protein abundance ([Figure 5F](#fig5){ref-type="fig"}) are expected to recognize both wild type and truncated versions of Rtls. To clarify this section of the Results, we have added the following text:

"To investigate endogenous Rtls protein in *S. rosetta* cells, we generated an antibody against residues 438--539, a region of the protein that is unique to Rtls and was expected to be present in all wild type and mutant Rtls isoforms ([Figure 5A](#fig5){ref-type="fig"}, Methods, [Figure 5--figure supplement 1](#fig5s1){ref-type="fig"}). Using this antibody, we found that total Rtls protein levels in mutant cells were ∼25% that of wild type cells ([Figure 5F](#fig5){ref-type="fig"}, [Figure 5--figure supplement 1B-D](#fig5s1){ref-type="fig"})."

We have also added the following section on Rtls epitope design to the Methods and provide the BLAST results below:

"The epitope is unique to Rtls and bears no resemblance to other predicted polypeptide sequences in *S. rosetta*; when the amino acid sequence of the epitope was used to search the full catalog of predicted *S. rosetta* proteins (using blastp), no other protein hit the epitope with an e-value less than 20 (i.e. the other hits were not statistically significant)".TargetScore (Bits)Expect*[S. rosetta]{.ul}*[: PTSG_03555.1: Rosetteless]{.ul}214.1570.0*[S. rosetta]{.ul}*[: PTSG_04911.1: hypothetical protein]{.ul}25.79422.958*[S. rosetta]{.ul}*[: PTSG_08579.1: hypothetical protein]{.ul}25.79427.127*[S. rosetta]{.ul}*[: PTSG_06697.1: hypothetical protein]{.ul}25.40934.553*[S. rosetta]{.ul}*[: PTSG_11988.1: hypothetical protein]{.ul}25.02446.272

Unlike conventional antibodies, the anti-Rtls antibody was generated as a genomic antibody, using a process that involves the introduction into rabbits of a DNA construct encoding the epitope, rather than the injection of purified protein (\[Brown, 2011\]; <http://www.sdix.com/Products/Custom-Antibody-Services/Antibody-Development/Genomic-Antibody-Technology.aspx>). This means that there was no possibility of inadvertently introducing additional bacterial or choanoflagellate epitopes during antibody generation. After the rabbit antiserum was harvested, the antibody was also affinity purified and analyzed by ELISA by SDIX.

We now turn to a discussion of the evidence for the specificity of the Rosetteless antibody:

One of the gold standard methods for establishing antibody specificity is to show that the signal is present in wild type samples, but absent or altered in mutant or knock out samples. In the case of Rosetteless, the staining patterns detected by immunofluorescence microscopy in mutant and wild type cells were strikingly different ([Figure 6C](#fig6){ref-type="fig"}), as were the levels of protein detected by dot blot ([Figure 5F](#fig5){ref-type="fig"}). To summarize the main text, Rtls mutants are missing both the bright staining at the center of rosettes (because the mutants do not produce rosettes) and the fainter, cell-membrane associated patches found in wild type single cells and chains. By dot blot, the anti-Rtls signal was reduced in mutant cells ([Figure 5F](#fig5){ref-type="fig"}, [Figure 5--figure supplement 1C](#fig5s1){ref-type="fig"}) even though the antibody should recognize both wild type and truncated Rtls isoforms. These differences between mutant and wild type detected by immunofluorescence microscopy and dot blot are most consistent with the interpretation that the majority of the antibody signal recognizes an epitope that is altered between mutant and wild type cells.

As an additional test of the specificity of the antibody, we used recombinant protein as a competitor during immunofluorescence and in dot blots. As requested by the reviewers, we have added documentation of the purity of the recombinant protein (by silver stain) and a Western blot of the recombinant protein as recognized by anti-Rtls to the manuscript ([Figure 5--figure supplement 1B](#fig5s1){ref-type="fig"}). The epitope has a predicted size of 38 kDa, and in our purifications it consistently appears at this size as a doublet, suggesting that some cleavage of the recombinant protein occurs in the bacteria. We indeed see this doublet as the predominant set of bands in the silver-stained recombinant protein sample and the only clear signal by Western blot.

In cells stained with the Rosetteless antibody, we see three main areas of immunofluorescence: (1) an extracellular meshwork in the center of rosettes, (2) in single cells and chains, a thin patch of membrane-associated staining that is most often found at the base of cells but sometimes seen in other parts of the cell, and (3) faint staining throughout the cell body in single cells and rosettes. If the Rosetteless antibody is pre-incubated with recombinant Rosetteless protein, the first two staining patterns (i.e. extracellular meshwork in center of rosettes and thin membrane-associated patches) disappear, presumably because those patterns result from antibody binding that specifically recognizes Rosetteless protein. The third pattern (i.e. faint staining throughout the cell body) persists following pre-incubation of the Rosetteless; we interpret this third pattern then to reflect either autofluorescence or non-specific staining. We are careful in the text to delineate that portion of the staining pattern that is specific to Rosetteless vs. that which reflects either autofluorescence or non-specific staining (in the legend for [Figure 6--figure supplement 2](#fig6s2){ref-type="fig"}): "In all cells following competition with the epitope there remained faint staining in the cell body; we thus infer that this is non-specific staining that does not reflect the distribution of Rtls protein in the cells").

Finally, we agree with the reviewers that a Western of *S. rosetta* cell lysates would be a valuable contribution to our efforts to validate the Rosetteless antibody. Indeed, we have been trying to establish Rosetteless Westerns on *S. rosetta* cell lysates for the past 5 months. However, likely due to the nature of Rosetteless protein itself, our attempts at these Westerns have failed.

We find either that there is no signal or that the primary signal detected by the anti-Rtls antibody by Western blot is of a very high molecular weight protein that does not enter the gel. We believe that the explanation for this phenomenon lies in the predicted mucin-like domains of the Rtls protein; in similar S/T-rich regions, mucins are heavily glycosylated, making these proteins sticky and quite large \[Harrop et al, 2011\]. Indeed, because such ECM proteins may be decorated with a variable number of sugars and often undergo other forms of posttranslational processing (e.g. cleavage into active forms), a single band on a Western may not even be expected for this type of protein.

Still, we have made a number of attempts to modify our Western blotting protocol to accommodate heavily glycosylated proteins and solubilize the mucous-like *S. rosetta* lysate. These attempts include: 1) various cell lysis and solubilization methods; 2) syringing and other means of physical shearing; 3) pre-incubation of cell lysates with deglycosylases; 4) resuspension of lysate in 8M urea; and 5) the use of low-percentage acrylamide and acrylamide/agarose gels. However, in all attempts to date, we observe either a high molecular weight signal that does not enter the gel, or no signal at all.

Due to the challenges in working with fully glycosylated mucins, the use of dot blots for semi-quantitative analyses of mucin levels is not unusual \[Harrop et al, 2011, Thomsson et al 2011\]. Therefore, because Western analysis of Rosetteless in *S. rosetta* cell lysates has not yet been possible, we used dot blot analysis to measure the relative abundance of Rosetteless protein in wild type and mutant cells \[Harrop et al, 2011, Thomsson et al 2011\]. As the reviewers pointed out, dot blots are not ideal, as the high concentration of protein can lead to non-specific binding of antibodies and, because the proteins are not separated by size, it is not possible to see whether the source of the signal is from one protein or multiple proteins. Nonetheless, for proteins that do not properly enter into gels, it can provide a means by which to estimate their abundance. Similar to our procedure for validating the antibody by immunofluorescence, we used the pre-incubation of the recombinant epitope with anti-Rtls antibody to compete away the staining that specifically recognized the Rosetteless protein. In [Figure 5--figure supplement 1B](#fig5s1){ref-type="fig"}, we demonstrate that this pre-incubation results in the loss of the majority, but not all, of the signal by dot blot. We also showed the residual signal following competition in the main figure ([Figure 5F](#fig5){ref-type="fig"}), and explained in the figure legend for this panel that it was only a "semi-quantitative" method, thereby acknowledging the limitations with dot blots.

In summary, although we have been unable to perform a Western analysis on *S. rosetta* cell lysates, we have a number of independent observations and experiments that are all consistent with the interpretation that the anti-Rtls antibody displays a high degree of specificity for Rtls protein.

We now discuss the relationship between Rosetteless protein and CTLD-containing proteins in animals:

We have generated a new figure, [Figure 5--figure supplement 2](#fig5s2){ref-type="fig"}, to illustrate the diversity of CTLD-containing proteins in choanoflagellates. This figure shows the full domain architecture of all CTLD-containing proteins in the *S. rosetta* and *M. brevicollis* genomes, with similar animal CTLD domain architectures for comparison.

While Rtls may indeed be a multicellularity gene, we have not yet demonstrated this to be the case. We refrain from making this assertion because it is not currently possible to clearly assess the homology between Rtls and animal lectins. Specifically, the divergence time between animals and choanoflagellates means that orthology assignments often must be made on the basis of domain architecture and organization instead of amino acid alignments. This analysis cannot be convincingly carried out for Rtls, as its simple domain architecture is not sufficiently diagnostic. Finally, within animals, C-type lectins are a family of rapidly evolving genes that exhibit extensive duplications and rearrangements among taxa (e.g. \[Sattler et al, 2012; Drickamer et al 1999\]). It is thus not currently possible to assign clear orthology relationships among many of the animal C-type lectins, much less between animal C-type lectins and more evolutionarily distant CTLD-containing proteins found in choanoflagellates and other eukaryotes (e.g. \[Wheeler et al, 2008\]). We discuss the limitations in identifying homologous C-type lectins in the legend for [Figure 5--figure supplement 2](#fig5s2){ref-type="fig"}.

[^1]: The percentage of cells in rosettes following induction.

[^2]: Swimming phenotypes of single cells.
